Older patients want more details, control of their bladder cancer treatment, study reveals
By
John Roszkowski
Jul 11, 2022
Older adults with advanced bladder cancer want more transparent communications from their healthcare providers when it comes to their diagnosis, treatment and care planning, new research has found.
Social support tied to lower mortality in older women with colorectal cancer
By
Alicia Lasek
Jan 23, 2020
Women with few social supports had 42% higher cancer mortality than their better-connected peers, a Kaiser Permanente study has found.
FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
By
Alicia Lasek
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...
Clinical Briefs for Wednesday, January 15
By
Alicia Lasek
Jan 14, 2020
‘Ageotypes’ study ties healthy behaviors to decrease in aging markers … Access to Medicare increases cancer detection, reduces cancer mortality rate … Psychiatric conditions linked to cognitive...
Common blood pressure drug once again found to contain cancer-causing chemicals
By
Alicia Lasek
Jun 19, 2019
The Federal Drug Administration has once again been alerted to high levels of cancer-causing chemicals found in batches of valsartan, a blood pressure medication used by millions.
Common measure of mortality also predicts cancer survival in seniors
By
Alicia Lasek (f3)
May 09, 2022
The Charlson Comorbidity Index accurately predicts morbidity in elderly patients with cancer, a new investigation has found.
Report: Accelerated aging linked to early-onset cancers
By
Kristen Fischer
Apr 18, 2024
People under the age of 55 are more likely to experience accelerated aging, and that’s linked to more early-onset solid tumors, according to research presented at the American Association for Cancer...
Two new drugs show promise for hard-to-treat breast, prostate cancers
By
Alicia Lasek
Jun 07, 2021
Cancer drug Lynparza (olaparib) reduced the risk of disease recurrence or death in certain aggressive breast cancers by 42% after surgery, while a new prostate cancer treatment improved survival by tracking...
Functional limitations more than double over 20 years among U.S. cancer survivors
By
Alicia Lasek
Jun 08, 2023
More lives are being saved from cancer, but the findings underscore the need for greater access to high quality survivorship care, investigators say.
Coffee drinkers have reduced risk of common liver cancer: study
By
Alicia Lasek
Nov 09, 2019
Middle-aged coffee drinkers have half the odds of developing a common liver cancer than their peers who don’t partake, say researchers.